Immunohistochemical Features of the 140 Analyzed Cases
| CD15 | ||
| Positive | 104 | (74.29%) |
| Negative | 36 | (25.71%) |
| LMP1 | ||
| Positive | 72 | (51.43%) |
| Negative | 68 | (48.57%) |
| bcl-2 | ||
| Positive | 86 | (61.43%) |
| Negative | 54 | (38.57%) |
| Rb | ||
| Positive | 137 | (97.85%) |
| Range | 1.3-40.5 | |
| Mean ± SD | 11.93 ± 8.70 | |
| p53 | ||
| Positive | 130 | (92.85%) |
| Range | 0.1-30.1 | |
| Mean ± SD | 4.06 ± 4.50 | |
| Growth fraction (Ki67) | ||
| Range | 0.3-41.0 | |
| Mean ± SD | 15.45 ± 9.40 |
| CD15 | ||
| Positive | 104 | (74.29%) |
| Negative | 36 | (25.71%) |
| LMP1 | ||
| Positive | 72 | (51.43%) |
| Negative | 68 | (48.57%) |
| bcl-2 | ||
| Positive | 86 | (61.43%) |
| Negative | 54 | (38.57%) |
| Rb | ||
| Positive | 137 | (97.85%) |
| Range | 1.3-40.5 | |
| Mean ± SD | 11.93 ± 8.70 | |
| p53 | ||
| Positive | 130 | (92.85%) |
| Range | 0.1-30.1 | |
| Mean ± SD | 4.06 ± 4.50 | |
| Growth fraction (Ki67) | ||
| Range | 0.3-41.0 | |
| Mean ± SD | 15.45 ± 9.40 |